Trials / Completed
CompletedNCT02931162
The Effects of Moxibustion on Ulcerative Colitis
Efficacy of Moxibustion Treatment on Patients With Ulcerative Colitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Shanghai Institute of Acupuncture, Moxibustion and Meridian · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To investigate the mechanism and effects of moxibustion on patients with ulcerative colitis.
Detailed description
A total of 60 patients with UC were randomly divided into the following 2 groups: a) Herb-partition moxibustion (Treatment Group) and b) Sham herb-partition moxibustion (Control Group). All patients in the trial will be treated with moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. MRI will be used to observe the changes on brain structure and function in patients with UC, and further research on the characteristics of the brain nerve response of these patients with herb-partition moxibustion. In addition, tissue morphology and molecular biology tests will be conducted to observe the regulation and expression of VDR and antimicrobial peptides in the intestinal mucosa of UC patients. All these steps will be done in order to provide experimental basis for the mechanism of the effects of herb-partition moxibustion in the treatment of UC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Herb-partitioned moxibustion | Patients receive herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. |
| OTHER | Sham herb-partitioned moxibustion | Patients receive sham herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. |
Timeline
- Start date
- 2016-08-23
- Primary completion
- 2018-12-31
- Completion
- 2019-12-31
- First posted
- 2016-10-12
- Last updated
- 2021-03-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02931162. Inclusion in this directory is not an endorsement.